nach oben

Reactions Weekly

Erschienen in:

01.07.2022 | Case report

Tapentadol

Abdominal distension, asthenia and pneumonia: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Jung JY, et al. A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naive or opioid-resistant patients. Supportive Care in Cancer 30: 6103-6112, No. 7, Jul 2022. Available from: URL: https://link.springer.com/article/10.1007/s00520-022-06992-w

Titel: Tapentadol
Abdominal distension, asthenia and pneumonia: 3 case reports
Publikationsdatum: 01.07.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-19423-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Paclitaxel

Immunosuppressants/nitric oxide/rituximab

Aciclovir

Covid-19-vaccine

Multiple drugs

CAR-T-cell-therapies/tocilizumab/unspecified steroids